Integra Lifesciences Holdings (IART) Restructuring Costs (2011 - 2012)
Integra Lifesciences Holdings (IART) reported Restructuring Costs of $49.3 million for Q2 2012, down 10.75% on a YoY basis from $55.2 million in Q3 2011, and up 5.56% sequentially from $46.7 million in Q1 2012.
Integra Lifesciences Holdings (IART) Restructuring Costs (2011 - 2012) Analysis & Trends
Integra Lifesciences Holdings (IART) has 2 years of Restructuring Costs data on file, last reported at $49.3 million in Q2 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.80 Bn | 176.50 Bn | 6.27 Bn |
| 2 | Stryker | 128.84 Bn | 125.96 Bn | 3.81 Bn |
| 3 | Medtronic | 108.59 Bn | 99.37 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.51 Bn | 67.06 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.18 Bn | 44.51 Bn | 1.29 Bn |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.16 Bn | 25.88 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - |
| 9 | Koninklijke Philips | 24.66 Bn | 21.54 Bn | 2.07 Bn |
| 10 | Integra Lifesciences Holdings | 1.50 Bn | 1.24 Bn | 216.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2012 | 49.27 Mn |
| Mar 31, 2012 | 46.68 Mn |
| Jun 30, 2011 | 55.20 Mn |
| Mar 31, 2011 | 39.39 Mn |